<DOC>
	<DOCNO>NCT00308373</DOCNO>
	<brief_summary>People type 2 diabetes mellitus ( earlier know maturity onset diabetes mellitus ) high blood level sugar fat . This study do determine excessive sugar enter blood people type 2 diabetes mellitus cause excessive fat . We also evaluate anti-diabetic medication , pioglitazone metformin take mouth work control blood sugar people diabetes .</brief_summary>
	<brief_title>Effects Fats Blood Glucose People With Without Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>The ultimate goal application determine cause ( ) type 2 diabetes mellitus . The role liver evolution type 2 diabetes extensively study muscle . This , part , due inherent difficulty measure hepatic insulin action human physiologic condition . Plasma free fatty acid ( FFA ) cause insulin resistance non-diabetic human commonly elevate people type 2 diabetes . We re-examine mechanism ( ) elevate FFA cause hepatic insulin resistance non-diabetic human , determine whether elevate FFA alter insulin induce suppression endogenous glucose production ( EGP ) diabetic human , whether due change glycogenolysis and/or gluconeogenesis . We also seek determine whether treatment pioglitazone ( thiazolidinedione ) blunt prevents FFA induce hepatic ( extrahepatic ) insulin resistance people type 2 diabetes whether effect FFA insulin action influence gender . We examine use thiazolidinediones reduces cortisol production change overall activity 11 beta hydroxysteroid dehydrogenase type 1 . We also investigate whether use thiazolidinediones alters objectively measure breathing sleepiness people type 2 diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>2,4-thiazolidinedione</mesh_term>
	<criteria>Fortytwo ( 21 woman , 21 men ) diabetic 31 ( 16 woman , 15 men ) match nondiabetic volunteer recruit . Diabetic volunteer whose HbA1c 79 % manage diet alone 6.58.5 % either sulfonylurea metformin eligible study . Diabetic nondiabetic subject healthy match age , gender , body mass index . Individuals body mass index less 19 great 44 kg/m2 exclude study avoid potential confounding effect may result extreme leanness obesity . Subjects great age 35 year age eligible study . Subjects less 35 year study order minimize possibility type 1 diabetes . Healthy diabetic subject mean participant history ) proliferate retinopathy ; b ) significant nephropathy , ( i.e. , plasma creatinine &gt; 1.4 mg/dl woman 1.5 mg/dl men , and/or proteinuria ) ; c ) symptomatic autonomic neuropathy ; ) clinically significant atherosclerotic vascular disease ( e.g. , history MI angina ) ; e ) know systemic illness . To ensure subject healthy , follow inform write consent , subject undergo history physical examination ; blood collect complete blood count chemistry group ; urine collect insure evidence infection clinically significant proteinuria . Body composition ( include percent fat , visceral fat , hepatic fat , lean body mass ) measure eligible subject GCRC body composition core use DEXA multiple cut CT scan . ( Diabetic volunteer undergo body composition study Part 2 protocol , 4 month therapy . Please see )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>